AB
DMAC icon

Amalgamated Bank’s DiaMedica Therapeutics DMAC Stock Holding History

Amalgamated Bank’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,066
Closed -$8K – 1956
2025
Q4 		$8K Buy
1,066
+164
+18% +$1.23K ﹤0.01% 2509
2025
Q3 		$6K Hold
902
– – ﹤0.01% 2668
2025
Q2 		$4K Buy
+902
New +$3.52K ﹤0.01% 2826

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Amalgamated Bank's DMAC Position: Q1 2026 in Review

Amalgamated Bank sold out of DiaMedica Therapeutics (DMAC) in Q1 2026, closing a stake of 1,066 shares — an estimated $8K sold.

Amalgamated Bank first reported a position in DMAC in Q2 2025 and held it in 3 quarters. The position peaked at $8K in Q4 2025. 99 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • Amalgamated Bank reported no remaining DiaMedica Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,066 DiaMedica Therapeutics shares in Q1 2026, an estimated $8K.
  • Amalgamated Bank first reported a position in DiaMedica Therapeutics in Q2 2025 and held it in 3 quarters.
  • Amalgamated Bank's DiaMedica Therapeutics position peaked at $8K in Q4 2025.
  • 99 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.